Covid-19 Impact on Global Human Microbiome Sequencing Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Human Microbiome Sequencing Revenue
• 1.4 Covid-19 Implications on Market by Type
  • 1.4.1 Global Human Microbiome Sequencing Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Next-Generation Sequencing
  • 1.4.3 Traditional Sequencing Technologies
  • 1.4.4 Other
• 1.5 Market by Application
  • 1.5.1 Global Human Microbiome Sequencing Market Share by Application: 2020 VS 2026
  • 1.5.2 Genome Analysis
  • 1.5.3 Metabolome Analysis
  • 1.5.4 Transcriptome Analysis
  • 1.5.5 Other Omics Analysis
• 1.6 Coronavirus Disease 2019 (Covid-19): Human Microbiome Sequencing Industry Impact
  • 1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
  • 1.6.2 Covid-19 Impact: Commodity Prices Indices
  • 1.6.3 Covid-19 Impact: Global Major Government Policy
• 1.7 Study Objectives
• 1.8 Years Considered

2 Global Growth Trends

• 2.1 Covid-19 Implications on Global Human Microbiome Sequencing Market Perspective (2015-2026)
• 2.2 Covid-19 Implications on Global Human Microbiome Sequencing Growth Trends by Regions
  • 2.2.1 Human Microbiome Sequencing Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Human Microbiome Sequencing Historic Market Share by Regions (2015-2020)
  • 2.2.3 Human Microbiome Sequencing Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Human Microbiome Sequencing Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Human Microbiome Sequencing Players (Opinion Leaders)

3 Covid-19 Implications on Competition Landscape by Key Players

• 3.1 Global Top Human Microbiome Sequencing Players by Market Size
  • 3.1.1 Global Top Human Microbiome Sequencing Players by Revenue (2015-2020)
  • 3.1.2 Global Human Microbiome Sequencing Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Human Microbiome Sequencing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Human Microbiome Sequencing Market Concentration Ratio
  • 3.2.1 Global Human Microbiome Sequencing Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Human Microbiome Sequencing Revenue in 2019
• 3.3 Human Microbiome Sequencing Key Players Head office and Area Served
• 3.4 Key Players Human Microbiome Sequencing Product Solution and Service
• 3.5 Date of Enter into Human Microbiome Sequencing Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Covid-19 Implications on Market Size by Type (2015-2026)

• 4.1 Global Human Microbiome Sequencing Historic Market Size by Type (2015-2020)
• 4.2 Global Human Microbiome Sequencing Forecasted Market Size by Type (2021-2026)

5 Covid-19 Implications on Market Size by Application (2015-2026)

• 5.1 Global Human Microbiome Sequencing Market Size by Application (2015-2020)
• 5.2 Global Human Microbiome Sequencing Forecasted Market Size by Application (2021-2026)

6 North America Impact of COVID-19

• 6.1 North America Human Microbiome Sequencing Market Size (2015-2020)
• 6.2 Human Microbiome Sequencing Key Players in North America (2019-2020)
• 6.3 North America Human Microbiome Sequencing Market Size by Type (2015-2020)
• 6.4 North America Human Microbiome Sequencing Market Size by Application (2015-2020)

7 Europe Impact of COVID-19

• 7.1 Europe Human Microbiome Sequencing Market Size (2015-2020)
• 7.2 Human Microbiome Sequencing Key Players in Europe (2019-2020)
• 7.3 Europe Human Microbiome Sequencing Market Size by Type (2015-2020)
• 7.4 Europe Human Microbiome Sequencing Market Size by Application (2015-2020)

8 China Impact of COVID-19

• 8.1 China Human Microbiome Sequencing Market Size (2015-2020)
• 8.2 Human Microbiome Sequencing Key Players in China (2019-2020)
• 8.3 China Human Microbiome Sequencing Market Size by Type (2015-2020)
• 8.4 China Human Microbiome Sequencing Market Size by Application (2015-2020)

9 Japan Impact of COVID-19

• 9.1 Japan Human Microbiome Sequencing Market Size (2015-2020)
• 9.2 Human Microbiome Sequencing Key Players in Japan (2019-2020)
• 9.3 Japan Human Microbiome Sequencing Market Size by Type (2015-2020)
• 9.4 Japan Human Microbiome Sequencing Market Size by Application (2015-2020)

10 Southeast Asia Impact of COVID-19

• 10.1 Southeast Asia Human Microbiome Sequencing Market Size (2015-2020)
• 10.2 Human Microbiome Sequencing Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Human Microbiome Sequencing Market Size by Type (2015-2020)
• 10.4 Southeast Asia Human Microbiome Sequencing Market Size by Application (2015-2020)

11 India Impact of COVID-19

• 11.1 India Human Microbiome Sequencing Market Size (2015-2020)
• 11.2 Human Microbiome Sequencing Key Players in India (2019-2020)
• 11.3 India Human Microbiome Sequencing Market Size by Type (2015-2020)
• 11.4 India Human Microbiome Sequencing Market Size by Application (2015-2020)

12 Central & South America Impact of COVID-19

• 12.1 Central & South America Human Microbiome Sequencing Market Size (2015-2020)
• 12.2 Human Microbiome Sequencing Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Human Microbiome Sequencing Market Size by Type (2015-2020)
• 12.4 Central & South America Human Microbiome Sequencing Market Size by Application (2015-2020)

13Key Players Profiles

• 13.1 Baseclear B.V.
  • 13.1.1 Baseclear B.V. Company Details
  • 13.1.2 Baseclear B.V. Business Overview and Its Total Revenue
  • 13.1.3 Baseclear B.V. Human Microbiome Sequencing Introduction
  • 13.1.4 Baseclear B.V. Revenue in Human Microbiome Sequencing Business (2015-2020))
  • 13.1.5 Baseclear B.V. Recent Development and Reaction to COVID-19
• 13.2 Beijing Genomics Institute (BGI) Genomics Co., Ltd
  • 13.2.1 Beijing Genomics Institute (BGI) Genomics Co., Ltd Company Details
  • 13.2.2 Beijing Genomics Institute (BGI) Genomics Co., Ltd Business Overview and Its Total Revenue
  • 13.2.3 Beijing Genomics Institute (BGI) Genomics Co., Ltd Human Microbiome Sequencing Introduction
  • 13.2.4 Beijing Genomics Institute (BGI) Genomics Co., Ltd Revenue in Human Microbiome Sequencing Business (2015-2020)
  • 13.2.5 Beijing Genomics Institute (BGI) Genomics Co., Ltd Recent Development and Reaction to COVID-19
• 13.3 Charles River Laboratories International Inc.
  • 13.3.1 Charles River Laboratories International Inc. Company Details
  • 13.3.2 Charles River Laboratories International Inc. Business Overview and Its Total Revenue
  • 13.3.3 Charles River Laboratories International Inc. Human Microbiome Sequencing Introduction
  • 13.3.4 Charles River Laboratories International Inc. Revenue in Human Microbiome Sequencing Business (2015-2020)
  • 13.3.5 Charles River Laboratories International Inc. Recent Development and Reaction to COVID-19
• 13.4 Clinical Microbiomics A/S
  • 13.4.1 Clinical Microbiomics A/S Company Details
  • 13.4.2 Clinical Microbiomics A/S Business Overview and Its Total Revenue
  • 13.4.3 Clinical Microbiomics A/S Human Microbiome Sequencing Introduction
  • 13.4.4 Clinical Microbiomics A/S Revenue in Human Microbiome Sequencing Business (2015-2020)
  • 13.4.5 Clinical Microbiomics A/S Recent Development and Reaction to COVID-19
• 13.5 Eurofins Scientific SE
  • 13.5.1 Eurofins Scientific SE Company Details
  • 13.5.2 Eurofins Scientific SE Business Overview and Its Total Revenue
  • 13.5.3 Eurofins Scientific SE Human Microbiome Sequencing Introduction
  • 13.5.4 Eurofins Scientific SE Revenue in Human Microbiome Sequencing Business (2015-2020)
  • 13.5.5 Eurofins Scientific SE Recent Development and Reaction to COVID-19
• 13.6 GENEWIZ, Inc.
  • 13.6.1 GENEWIZ, Inc. Company Details
  • 13.6.2 GENEWIZ, Inc. Business Overview and Its Total Revenue
  • 13.6.3 GENEWIZ, Inc. Human Microbiome Sequencing Introduction
  • 13.6.4 GENEWIZ, Inc. Revenue in Human Microbiome Sequencing Business (2015-2020)
  • 13.6.5 GENEWIZ, Inc. Recent Development and Reaction to COVID-19
• 13.7 Illumina, Inc.
  • 13.7.1 Illumina, Inc. Company Details
  • 13.7.2 Illumina, Inc. Business Overview and Its Total Revenue
  • 13.7.3 Illumina, Inc. Human Microbiome Sequencing Introduction
  • 13.7.4 Illumina, Inc. Revenue in Human Microbiome Sequencing Business (2015-2020)
  • 13.7.5 Illumina, Inc. Recent Development and Reaction to COVID-19
• 13.8 Novogene Corporation
  • 13.8.1 Novogene Corporation Company Details
  • 13.8.2 Novogene Corporation Business Overview and Its Total Revenue
  • 13.8.3 Novogene Corporation Human Microbiome Sequencing Introduction
  • 13.8.4 Novogene Corporation Revenue in Human Microbiome Sequencing Business (2015-2020)
  • 13.8.5 Novogene Corporation Recent Development and Reaction to COVID-19
• 13.9 OraSure Technologies, Inc.
  • 13.9.1 OraSure Technologies, Inc. Company Details
  • 13.9.2 OraSure Technologies, Inc. Business Overview and Its Total Revenue
  • 13.9.3 OraSure Technologies, Inc. Human Microbiome Sequencing Introduction
  • 13.9.4 OraSure Technologies, Inc. Revenue in Human Microbiome Sequencing Business (2015-2020)
  • 13.9.5 OraSure Technologies, Inc. Recent Development and Reaction to COVID-19
• 13.10 Oxford Nanopore Technologies, Inc.
  • 13.10.1 Oxford Nanopore Technologies, Inc. Company Details
  • 13.10.2 Oxford Nanopore Technologies, Inc. Business Overview and Its Total Revenue
  • 13.10.3 Oxford Nanopore Technologies, Inc. Human Microbiome Sequencing Introduction
  • 13.10.4 Oxford Nanopore Technologies, Inc. Revenue in Human Microbiome Sequencing Business (2015-2020)
  • 13.10.5 Oxford Nanopore Technologies, Inc. Recent Development and Reaction to COVID-19
• 13.11 Pacific Biosciences of California, Inc.
  • 10.11.1 Pacific Biosciences of California, Inc. Company Details
  • 10.11.2 Pacific Biosciences of California, Inc. Business Overview and Its Total Revenue
  • 10.11.3 Pacific Biosciences of California, Inc. Human Microbiome Sequencing Introduction
  • 10.11.4 Pacific Biosciences of California, Inc. Revenue in Human Microbiome Sequencing Business (2015-2020)
  • 10.11.5 Pacific Biosciences of California, Inc. Recent Development and Reaction to COVID-19
• 13.12 QIAGEN N.V.
  • 10.12.1 QIAGEN N.V. Company Details
  • 10.12.2 QIAGEN N.V. Business Overview and Its Total Revenue
  • 10.12.3 QIAGEN N.V. Human Microbiome Sequencing Introduction
  • 10.12.4 QIAGEN N.V. Revenue in Human Microbiome Sequencing Business (2015-2020)
  • 10.12.5 QIAGEN N.V. Recent Development and Reaction to COVID-19
• 13.13 Second Genome, Inc.
  • 10.13.1 Second Genome, Inc. Company Details
  • 10.13.2 Second Genome, Inc. Business Overview and Its Total Revenue
  • 10.13.3 Second Genome, Inc. Human Microbiome Sequencing Introduction
  • 10.13.4 Second Genome, Inc. Revenue in Human Microbiome Sequencing Business (2015-2020)
  • 10.13.5 Second Genome, Inc. Recent Development and Reaction to COVID-19
• 13.14 Thermo Fisher Scientific Inc.
  • 10.14.1 Thermo Fisher Scientific Inc. Company Details
  • 10.14.2 Thermo Fisher Scientific Inc. Business Overview and Its Total Revenue
  • 10.14.3 Thermo Fisher Scientific Inc. Human Microbiome Sequencing Introduction
  • 10.14.4 Thermo Fisher Scientific Inc. Revenue in Human Microbiome Sequencing Business (2015-2020)
  • 10.14.5 Thermo Fisher Scientific Inc. Recent Development and Reaction to COVID-19
• 13.15 Viome, Inc.
  • 10.15.1 Viome, Inc. Company Details
  • 10.15.2 Viome, Inc. Business Overview and Its Total Revenue
  • 10.15.3 Viome, Inc. Human Microbiome Sequencing Introduction
  • 10.15.4 Viome, Inc. Revenue in Human Microbiome Sequencing Business (2015-2020)
  • 10.15.5 Viome, Inc. Recent Development and Reaction to COVID-19
• 13.16 CosmosID
  • 10.16.1 CosmosID Company Details
  • 10.16.2 CosmosID Business Overview and Its Total Revenue
  • 10.16.3 CosmosID Human Microbiome Sequencing Introduction
  • 10.16.4 CosmosID Revenue in Human Microbiome Sequencing Business (2015-2020)
  • 10.16.5 CosmosID Recent Development and Reaction to COVID-19
• 13.17 Leucine Rich Bio Pvt. Ltd.
  • 10.17.1 Leucine Rich Bio Pvt. Ltd. Company Details
  • 10.17.2 Leucine Rich Bio Pvt. Ltd. Business Overview and Its Total Revenue
  • 10.17.3 Leucine Rich Bio Pvt. Ltd. Human Microbiome Sequencing Introduction
  • 10.17.4 Leucine Rich Bio Pvt. Ltd. Revenue in Human Microbiome Sequencing Business (2015-2020)
  • 10.17.5 Leucine Rich Bio Pvt. Ltd. Recent Development and Reaction to COVID-19
• 13.18 Microba
  • 10.18.1 Microba Company Details
  • 10.18.2 Microba Business Overview and Its Total Revenue
  • 10.18.3 Microba Human Microbiome Sequencing Introduction
  • 10.18.4 Microba Revenue in Human Microbiome Sequencing Business (2015-2020)
  • 10.18.5 Microba Recent Development and Reaction to COVID-19
• 13.19 Microbiome Insights Inc.
  • 10.19.1 Microbiome Insights Inc. Company Details
  • 10.19.2 Microbiome Insights Inc. Business Overview and Its Total Revenue
  • 10.19.3 Microbiome Insights Inc. Human Microbiome Sequencing Introduction
  • 10.19.4 Microbiome Insights Inc. Revenue in Human Microbiome Sequencing Business (2015-2020)
  • 10.19.5 Microbiome Insights Inc. Recent Development and Reaction to COVID-19
• 13.20 Molzym GmbH & Co. KG
  • 10.20.1 Molzym GmbH & Co. KG Company Details
  • 10.20.2 Molzym GmbH & Co. KG Business Overview and Its Total Revenue
  • 10.20.3 Molzym GmbH & Co. KG Human Microbiome Sequencing Introduction
  • 10.20.4 Molzym GmbH & Co. KG Revenue in Human Microbiome Sequencing Business (2015-2020)
  • 10.20.5 Molzym GmbH & Co. KG Recent Development and Reaction to COVID-19

14Analyst's Viewpoints/Conclusions

15Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer